| Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ... Science 348 (6230), 124-128, 2015 | 8508 | 2015 |
| The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy JJ Havel, D Chowell, TA Chan Nature Reviews Cancer 19 (3), 133-150, 2019 | 2166 | 2019 |
| Tumor and microenvironment evolution during immunotherapy with nivolumab N Riaz, JJ Havel, V Makarov, A Desrichard, WJ Urba, JS Sims, FS Hodi, ... Cell 171 (4), 934-949. e16, 2017 | 1979 | 2017 |
| The head and neck cancer immune landscape and its immunotherapeutic implications R Mandal, Y Şenbabaoğlu, A Desrichard, JJ Havel, MG Dalin, N Riaz, ... JCI insight 1 (17), e89829, 2016 | 754 | 2016 |
| Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response R Mandal, RM Samstein, KW Lee, JJ Havel, H Wang, C Krishna, ... Science 364 (6439), 485-491, 2019 | 517 | 2019 |
| Immunogenic neoantigens derived from gene fusions stimulate T cell responses W Yang, KW Lee, RM Srivastava, F Kuo, C Krishna, D Chowell, ... Nature medicine 25 (5), 767-775, 2019 | 348 | 2019 |
| The role of neoantigens in response to immune checkpoint blockade N Riaz, L Morris, JJ Havel, V Makarov, A Desrichard, TA Chan International immunology 28 (8), 411-419, 2016 | 174 | 2016 |
| Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy N Riaz, JJ Havel, SM Kendall, V Makarov, LA Walsh, A Desrichard, ... Nature genetics 48 (11), 1327-1329, 2016 | 142 | 2016 |
| Commensal bacteria stimulate antitumor responses via T cell cross-reactivity CA Bessell, A Isser, JJ Havel, S Lee, DR Bell, JW Hickey, ... JCI insight 5 (8), e135597, 2020 | 138 | 2020 |
| Non-cell-autonomous cancer progression from chromosomal instability J Li, MJ Hubisz, EM Earlie, MA Duran, C Hong, AA Varela, E Lettera, ... Nature 620 (7976), 1080-1088, 2023 | 113 | 2023 |
| Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions MG Dalin, N Katabi, M Persson, KW Lee, V Makarov, A Desrichard, ... Nature communications 8 (1), 1197, 2017 | 103 | 2017 |
| Inhibition of protein-protein interactions: non-cellular assay formats MR Arkin, MA Glicksman, H Fu, JJ Havel, Y Du Assay Guidance Manual [Internet], 2012 | 77 | 2012 |
| Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway JJ Havel, Z Li, D Cheng, J Peng, H Fu Oncogene 34 (12), 1487-1498, 2015 | 66 | 2015 |
| β2-Microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells WC Huang, JJ Havel, HE Zhau, WP Qian, HW Lue, CY Chu, T Nomura, ... Clinical Cancer Research 14 (17), 5341-5347, 2008 | 48 | 2008 |
| ImmunoMap: a bioinformatics tool for T-cell repertoire analysis JW Sidhom, CA Bessell, JJ Havel, A Kosmides, TA Chan, JP Schneck Cancer immunology research 6 (2), 151-162, 2018 | 45 | 2018 |
| Enabling systematic interrogation of protein–protein interactions in live cells with a versatile ultra-high-throughput biosensor platform XL Mo, Y Luo, AA Ivanov, R Su, JJ Havel, Z Li, FR Khuri, Y Du, H Fu Journal of molecular cell biology 8 (3), 271-281, 2016 | 39 | 2016 |
| AKT1, LKB1, and YAP1 revealed as MYC interactors with NanoLuc-based protein-fragment complementation assay X Mo, Q Qi, AA Ivanov, Q Niu, Y Luo, J Havel, R Goetze, S Bell, ... Molecular pharmacology 91 (4), 339-347, 2017 | 34 | 2017 |
| PRAS40 promotes NF-κB transcriptional activity through association with p65 G Zhu, Q Qi, JJ Havel, Z Li, Y Du, X Zhang, H Fu Oncogenesis 6 (9), e381-e381, 2017 | 17 | 2017 |
| Qa-1b Modulates Resistance to Anti–PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing X Zhang, E Sabio, C Krishna, X Ma, J Wang, H Jiang, JJ Havel, TA Chan Molecular Cancer Research 19 (6), 1076-1084, 2021 | 16 | 2021 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 13 | 2016 |
